E-book
The power of using integrated data to understand drug performance
These real-world examples show how integrated data can help you improve medication adherence, track patient journeys, evaluate total cost of care and more.
Dig deeper into the evolving role of real-world evidence
Clinicogenomics linked data advances research
Clinicogenomics data can fuel all stages of development.
Four steps to an enterprise data strategy
Maximize data investments.
Is Your Real-World Data Research Ready?
Go behind the scenes of real-world data.
Insights (72)
Filter
-
E-book: The foundational forces affecting pharma today and beyond
What are 3 key trends manufacturers should consider when planning for 2025? Advisory Board and Optum® Life Sciences experts share their insights in this e-book.
-
Reexamine the effect of the Inflation Reduction Act
Learn how to prepare for tough conversations and questions related to the Inflation Reduction Act’s health care policies with data and evidence.
-
Unlock clinical insights with NLP technology
Learn about natural language processing (NLP) challenges and opportunities in the real-world data (RWD) space from Optum® NLP experts.
-
The value of clinical notes: Beyond the structured data field
What more is there to the patient story? Get deeper data insight into patient-clinician interactions with de-identified clinical notes.
-
Challenges and opportunities with clinicogenomic data
Genomic data linked to the longitudinal health record hold great insight. How should researchers think about and use these powerful data?
-
The 6 trends shaping pharma strategies in 2024
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
-
How race and ethnicity data can bridge the health equity gap
The life sciences industry needs robust real-world data. For that data to reflect real-world populations, you need race and ethnicity data.
-
Case study: Identifying patients at risk for a bone break
Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.
-
Break down silos in clinical trial design with RWD and tools
Clinical trial protocol design and feasibility often occur in silos. Learn how to make the overall trial design process more effective.
-
Catalyze the use of RWE in the life sciences industry
Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.
-
Natural language processing (NLP) methods for RWD insights
NLP systems allow us to draw insights from billions of unstructured medical notes. Learn more about our NLP methodology in this white paper.
-
Webinar: Solving trial recruitment challenges with data
Learn from clinical trial leaders how you can address recruitment roadblocks by unlocking real-world data (RWD).
-
What if pragmatic trials were more practical?
Pragmatic trials look increasingly attractive to researchers, but they’re tough to execute. Learn how to simplify the process.
-
Integrated RWD: the key to accelerating innovation
To maximize the value of clinical innovations, you need dimensional, robust data. Learn about leveraging integrated cost and clinical data.
-
Toward Outcomes-Based Payments
Learn from industry leaders about the push to generate evidence and demonstrate value for health care provider value.
-
An interview with Jamie Freedman, MD, PhD, and Shalini Mohan, MD
This interview about health equity and clinical trials is part of the "Let's talk" conversation series.
-
Connecting Patients to Clinical Trials in Community Care Settings
Learn how real-world data can increase access beyond traditional research sites.
-
6 guiding steps for selecting a fit-for-purpose data set
Using RWD that are not fit for purpose can waste time and money. Review 6 simple steps to guide your research towards the right data.
-
Promoting patient access to gene therapies for rare disorders
Optum Life Sciences experts discuss value-based contracts at the 5th Annual Gene Therapy for Rare Disorders Conference.
-
Getting ahead of the mental health crisis
See how leaders are advancing data strategies, screenings and exploring ways to connect consumers to mental health support.
-
Interview with Jason Spangler on value assessment frameworks
This interview is part of the "Let's talk" conversation series.
-
4 ways small and emerging biopharma can harness RWD now
Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance your ability to innovate.
-
What if providers’ clinical data were research-ready?
Providers collect data about patients every day. But what should they be considering — and doing — to put their clinical data to good use?
-
Case study: Improving SGLT2i therapy guideline adherence
Article that covers OLS and Boehringer Ingelheim collaboration to increase adherence for patients with diabetes and CVD.